Context is key for FLT3-ITD

被引：0
|
作者：
Meyer, Sara E. [1 ]
机构：
[1] Thomas Jefferson Univ, Philadelphia, PA 19144 USA
来源：
BLOOD | 2023年 / 141卷 / 12期
关键词：
INTERNAL TANDEM DUPLICATION; KNOCK-IN; MYELOPROLIFERATIVE DISEASE; MUTATIONS; LEUKEMIA;
D O I：
10.1182/blood.2022019135
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In this issue of Blood, Li et al1 report age and co-mutation contexts wherein FLT3 internal tandem duplication (ITD) orchestrates unique transcriptional and epigenetic programs to deliver distinct functional outputs from myeloid progenitor cells.
引用
收藏
页码：1373 / 1374
页数：2
相关论文
共 50 条
  • [31] Depalmitoylation rewires FLT3-ITD signaling and exacerbates leukemia progression
    Lv, Kaosheng
    Ren, Jian-Gang
    Han, Xu
    Gui, Jun
    Gong, Chujie
    Tong, Wei
    BLOOD, 2021, 138 (22) : 2244 - 2255
  • [32] Characterizing Transcriptional and Epigenetic Signatures Induced By FLT3-ITD Activation
    Spitzer, Barbara
    Guryanova, Olga A.
    Abdel-Wahab, Omar
    Kucine, Nicole
    Adli, Mazhar
    Berman, Jason N.
    Meshinchi, Soheil
    Bernstein, Bradley
    Pelossof, Raphael
    Leslie, Christina
    Levine, Ross L.
    BLOOD, 2014, 124 (21)
  • [33] RUNX1 cooperates with FLT3-ITD to induce leukemia
    Behrens, Kira
    Maul, Katrin
    Tekin, Nilguen
    Kriebitzsch, Neele
    Indenbirken, Daniela
    Prassolov, Vladimir
    Mueller, Ursula
    Serve, Hubert
    Cammenga, Jorg
    Stocking, Carol
    JOURNAL OF EXPERIMENTAL MEDICINE, 2017, 214 (03): : 737 - 752
  • [34] Partnering with PARP inhibitors in acute myeloid leukemia with FLT3-ITD
    Dellomo, Anna J.
    Baer, Maria R.
    Rassool, Feyruz V.
    CANCER LETTERS, 2019, 454 : 171 - 178
  • [35] FLT3-ITD and its current role in acute myeloid leukaemia
    Alejandro Lagunas-Rangel, Francisco
    Chavez-Valencia, Venice
    MEDICAL ONCOLOGY, 2017, 34 (06)
  • [36] Activation mechanisms of STAT5 by oncogenic Flt3-ITD
    Choudhary, Chunaram
    Brandts, Christian
    Schwable, Joachim
    Tickenbrock, Lara
    Sargin, Buelent
    Ueker, Andrea
    Boehmer, Frank-D.
    Berdel, Wolfgang E.
    Mueller-Tidow, Carsten
    Serve, Hubert
    BLOOD, 2007, 110 (01) : 370 - 374
  • [37] A combinatorial therapeutic approach to enhance FLT3-ITD AML treatment
    Long, Jun
    Chen, Xinjie
    Shen, Yan
    Lei, Yichen
    Mu, Lili
    Wang, Zhen
    Xiang, Rufang
    Gao, Wenhui
    Wang, Lining
    Wang, Ling
    Jiang, Jieling
    Zhang, Wenjun
    Lu, Huina
    Dong, Yan
    Ding, Yi
    Zhu, Honghu
    Hong, Dengli
    Sun, Yi Eve
    Hu, Jiong
    Liang, Aibin
    CELL REPORTS MEDICINE, 2023, 4 (11)
  • [38] Impact of FLT3-ITD length on prognosis of acute myeloid leukemia
    Liu, Song-Bai
    Dong, Hao-Jie
    Bao, Xie-Bing
    Qiu, Qiao-Cheng
    Li, Hong-Zhi
    Shen, Hong-Jie
    Ding, Zi-Xuan
    Wang, Chao
    Chu, Xiao-Ling
    Yu, Jing-Qiu
    Tao, Tao
    Li, Zheng
    Tang, Xiao-Wen
    Chen, Su-Ning
    Wu, De-Pei
    Li, Ling
    Xue, Sheng-Li
    HAEMATOLOGICA, 2019, 104 (01) : E9 - E12
  • [39] Degrading FLT3-ITD protein by proteolysis targeting chimera (PROTAC)
    Chen, Yong
    Yuan, Xue
    Tang, Minghai
    Shi, Mingsong
    Yang, Tao
    Liu, Kongjun
    Deng, Dexin
    Chen, Lijuan
    BIOORGANIC CHEMISTRY, 2022, 119
  • [40] FLT3-ITD突变检测及其临床意义
    马亮
    马一盖
    中日友好医院学报, 2011, (03) : 178 - 180+184
12345